Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E 2 levels

We developed S (+)-flurbiprofen plaster (SFPP), a novel NSAID patch containing S (+)-flurbiprofen (SFP), a potent cyclooxygenase (COX) inhibitor. The purpose of this study was to assess efficacy of SFPP by analysing its effect on the gait disturbance and measuring the prostaglandin E (PGE ) producti...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmacy and pharmacology
Main Authors Fukumoto, Ayaka, Tajima, Kyoko, Hori, Miyuki, Toda, Yoshihisa, Kaku, Shinsuke, Matsumoto, Hideo
Format Journal Article
LanguageEnglish
Published England 01.07.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:We developed S (+)-flurbiprofen plaster (SFPP), a novel NSAID patch containing S (+)-flurbiprofen (SFP), a potent cyclooxygenase (COX) inhibitor. The purpose of this study was to assess efficacy of SFPP by analysing its effect on the gait disturbance and measuring the prostaglandin E (PGE ) production in synovial fluid in a rat model of knee arthritis. Knee inflammation was induced in rats by intra-articular injection of a yeast suspension. Subsequently, an NSAID patch containing SFP, ketoprofen or loxoprofen was applied over the affected knee. Gait was assessed at 2, 4 and 6 h after application of the patch. The PGE concentration in the synovial fluid was measured after the gait assessment. Application of SFPP (0.125, 0.25, 0.5 or 1 mg/sheet) was followed by a decrease in the visual gait score at all the doses examined. In the case of the other two NSAID patches, only the ketoprofen patch (1 or 2 mg/sheet) and loxoprofen patch (5 mg/sheet) produced a decrease in the visual gait score. All of the NSAID patches decreased the PGE production in the synovial fluid. These results suggest the potential usefulness of SFPP as an analgesic patch in patients with inflammatory joint pain.
ISSN:2042-7158
DOI:10.1111/jphp.12914